Prednisolone and azathioprine worsen the cyclosporine A-induced oxidative phosphorylation decrease of kidney mitochondria

Life Sciences

Volumn 61, Issue 6, 1997, Pages 659-666

  Simon, Nicolas ^a   Zini, Roland ^a   Morin, Christophe ^a   Brée, Françoise ^a   Tillement, Jean Paul ^a  

^a FACULTÉ DE MÉDECINE   (France)

Author keywords

Azathioprine; Cyclosporine; Mitochondria; Prednisolone

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; SUCCINIC ACID;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; KIDNEY; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; NEPHROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; RAT; RESPIRATION CONTROL;

ANIMALS; AZATHIOPRINE; CALCIUM; CYCLOSPORINE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; MITOCHONDRIA; MITOCHONDRIAL SWELLING; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PREDNISOLONE; RATS; RATS, WISTAR; SUCCINATES; SUCCINIC ACID;

ANIMALIA;

EID: 0030845472     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00442-6     Document Type: Article

References (17)

1. B.D. MYERS, R. SIBLEY, L. NEWTON, S.J. TOMLANOVICH, C. BOSHKOS, E. STINSON, J.A. LUETSCHER, D.J. WHITNEY, D. KRASNY, N.S. COPLON and M.G. PERLROTH, Kidney int. 33 590-600 (1988).
2. P.G. MCNALLY and J. FEEHALLY, Nephrol. Dial. Transplant. 7 791-804 (1992).
3. K. JUNG and M. PERGANDE, FEBS Lett. 183 167-169 (1985).
4. M.C. BENNETT, G. W. MLADY, M. FLESHNER and G.M. ROSE, Proc. Natl. Acad. Sci. USA 93 1330-1334 (1996)
5. T. STRZELECKI, B.R. McGRAW and R.B. KHAULI, Transplantation Proceedings 21 182-183 (1989).
6. W.M. BENNETT, A. DeMATTOS, M.M. MEYER, T. ANDOH and J.M. BARRY, Kidney International. 50 1089-1100 (1996).
7. J. PFEILSCHIFTER, Biochem. Pharmacol. 37 4205-4210 (1988)
8. A. Lo RUSSO, A.-C. PASSAQUIN, P. ANDRÉ, M. SKUTELLA and U.T. RÜEGG, Br. J. Pharmacol. 118 885-892 (1996).
9. T. JIANG and D. Jr. ACOSTA, Toxicology 95 155-166 (1995)
10. N. FOURNIER, G. DUCET and A. CREVAT, J. Bioenerg. Biomembr. 19 297-303 (1987).
11. P. BERNARDI, K.M. BROEKEMEIER and D.R. PFEIFFER, J. Bioenerg. Biomembr. 25 509-517 (1994).
12. P. HALESTRAP and A. DAVIDSON, Biochem. J. 268 153-160 (1990).
13. C. RICHTER, M. THEUS and J. SCHLEGEL, Biochem. Pharmacol. 40 779-782 (1990).
14. A.K. GROEN, R.J.A. WANDERS, H.V. WESTERHOFF, R. Van Der MEER and T.M. TAGER, J. Biol. Chem. 257 2754-2757 (1982).
15. G.P. DAVEY and J.B. CLARK, J. Neurochem. 66 1617-1624 (1996).
16. R. MORENO-SANCHEZ, S. DEVARS, F. LOPEZ-GOMEZ, A. URIBE and N. CORONA, Biochem. Biophys. Acta 1060 284-292 (1991).
17. M.D. SALDUCCI, A.M. CHAUVET-MONGES, J.P. TILLEMENT, E. ALBENGRES, B. TESTA, P. CARRUPT and A CREVAT, J. Pharmacol. Exp. Ther. 277 417-422 (1996).